Become a member

Quick Registration

Full Registration Benefits -

Free Homepages for Doctors

Free Homepages for Hospitals

Free Homepages for Medical Conference

Free Homepages for NGO's

Personal Health Record Creation

Access to all Medical Slides

Access to all Jobs & Products Sale

Explore Medindia

Medindia » Drugs » FDA Approved Drugs

FDA Approved Drugs in 2011

Comprehensive list of FDA approved drugs by year. Drug information includes the drug name and indication of use.

Browse the FDA Approved Drugs by year

2013 2012 2011 2010 2009 2008

January	February	March	April
May	June	July	August
September	October	November	December

January

Etravirine FDA Approves New Dosage Strength for Intelence (etravirine)	Fentanyl Sublingual Tablets FDA Approval for Abstral (Fentanyl) Sublingual Tablets
Ioflupane I 123 FDA Approves DaTscan (Ioflupane I 123 Injection) for Visualization of Dopamine Transporters in Patients with Suspected Parkinsonian Syndromes	Spinosad FDA Approves Natroba (spinosad) Head Lice Treatment for Children and Adults
Vilazodone Hydrochloride FDA Approves Viibryd (vilazodone) to Treat Major Depressive Disorder	Rituximab FDA Approves Rituxan (rituximab) for First-Line Maintenance Use in Follicular Lymphoma
Gabapentin Depomed Announces US Food and Drug Administration Approval of Gralise (gabapentin) Once-Daily Tablets for Treatment of Post-Herpetic Neuralgia

February

Hydroxy Progesterone FDA Approves Makena (hydroxyprogesterone caproate) to Reduce Risk of Preterm Birth in At-Risk Pregnant Women	Atazanavir Reyataz (atazanavir) label revised, adding dosing recommendations for pregnancy and postpartum period
Aripiprazole Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate	Azilsartan Medoxomil FDA Approves Edarbi (azilsartan medoxomil) to Treat High Blood Pressure
Roflumilast FDA Approves Daliresp (roflumilast) to Treat Chronic Obstructive Pulmonary Disease

March

Rufinamide FDA Approves Banzel (rufinamide) Oral Suspension, 40 mg/mL	Belimumab FDA Approves Benlysta (belimumab) to Treat Lupus
Gadobutrol U.S. FDA Approves Bayer's Gadavist (gadobutrol) Injection for MRI of the Central Nervous System	Zoster Vaccine Live FDA Expands Indication for Zostavax (zoster vaccine live), Merck's Shingles Vaccine, to Include Adults Ages 50 to 59
Imiquimod FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts	Ipilimumab FDA Approves Yervoy (ipilimumab) for Late-Stage Melanoma
Nevirapine FDA Approves Viramune XR (nevirapine) 400 mg extended release tablet	Peginterferon Alfa 2 B FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement

April

Vandetanib FDA Approves Orphan Drug Caprelsa (vandetanib) for Advanced Medullary Thyroid Cancer	Paliperidone Invega (paliperidone) Approved as Treatment for Schizophrenia in Adolescents
Rituximab FDA Approves Rituxan (rituximab) to Treat Two Rare Disorders	Meningococcal Conjugate Vaccine FDA Approves Menactra (meningococcal conjugate vaccine) to Prevent Meningococcal Disease in Infants and Toddlers
Famotidine And Ibuprofen Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)	Lamotrigine FDA Approves Lamictal XR (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients
Abiraterone acetate FDA Approves Zytiga (abiraterone) for Late-Stage Prostate Cancer

May

Levoleucovorin FDA Approves Fusilev (levoleucovorin) for Use in Patients with Colorectal Cancer	Esomeprazole FDA Approves Nexium I.V. (Esomeprazole Sodium) for the Treatment of Gastroesophageal Reflux Disease (GERD) With Erosive Esophagitis in Pediatric and Adolescent Patients
Linagliptin FDA Approves Tradjenta (linagliptin) for Type 2 Diabetes	Everolimus Novartis Gains FDA Approval for Afinitor (everolimus) As First New Treatment in Nearly Three Decades for Patients With Advanced Pancreatic NET
Influenza Virus Vaccine FDA Licenses Fluzone (influenza virus vaccine, inactivated) Intradermal - Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection	Boceprevir FDA Approves Merck's Victrelis (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor
Rilpivirine FDA Approves New HIV Treatment Edurant (rilpivirine)	Sunitinib FDA Approves Sutent (sunitinib malate) for Rare Type of Pancreatic Cancer
Telaprevir FDA Approves Incivek (telaprevir) for People with Hepatitis C	Fidaxomicin FDA Approves Dificid (fidaxomicin) for Clostridium difficile Infection

June

Insulin Lispro FDA Approves Updates to Lilly's Humalog (insulin lispro injection [rDNA origin]) Label	Ezogabine Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga (ezogabine)
Pancrelipase Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis	Belatacept FDA Approves Nulojix (belatacept) for Kidney Transplant Patients
Romidepsin FDA Grants Accelerated Approval of Istodax (romidepsin) As Treatment for Patients with Peripheral T-Cell Lymphoma Who Have Received at Least One Prior Therapy	Oxycodone Hydrochloride Pfizer and Acura Announce FDA Approval of Oxecta (Oxycodone HCl, USP) CII
Leuprolide Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer	Nitroglycerin Ointment ProStrakan Receives FDA Approval for Rectiv (nitroglycerin) for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures
Azficel-T Fibrocell Science, Inc. Announces FDA Approval for laViv (azficel-T)	Chlorpheniramine- Hydrocodone- Pseudoephedrine FDA Approves Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution
Hydrocodone And Pseudoephedrine FDA Approves Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution

July

Rivaroxaban FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery	Indacaterol FDA Approves Arcapta (indacaterol) Neohaler to treat Chronic Obstructive Pulmonary Disease
Mesalamine(Mesalazine) Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis	Ticagrelor FDA approves blood-thinning drug Brilinta (ticagrelor) to treat acute coronary syndromes
Incobotulinumtoxina Merz Aesthetics Announces FDA Approval Of Xeomin (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients	Immune globulin intravenous Baxter Announces FDA Approval of Subcutaneous Route of Administration for Gammagard Liquid (immune globulin infusion (human)) for Patients with Primary Immunodeficiency
Colesevelam Hcl Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juice or Diet Soft Drinks	Imiquimod FDA Approves Zyclara (imiquimod) Cream, 2.5% for the Treatment of Actinic Keratoses
Abatacept U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis	Rivaroxaban FDA Approves Xarelto (rivaroxaban) to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm

August

Antivenom FDA Approves Anascorp (antivenom (centruroides scorpion)) - First Specific Treatment for Scorpion Stings	Emtricitabine- Rilpivirine- Tenofovir U.S. Food and Drug Administration Approves Gilead Sciences' Complera (emtricitabine, rilpivirine and tenofovir disoproxil fumarate), a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Na�ve Adults
Mometasone Intersect ENT Announces U.S. Food and Drug Administration Approval for Propel - First Drug Releasing Implant for Chronic Sinusitis Patients	Vemurafenib Tablet FDA Approves Zelboraf (vemurafenib) and Companion Diagnostic Test for Late-Stage Skin Cancer
Brentuximab Vedotin FDA Approves Adcetris (brentuximab vedotin) to Treat Two Types of Lymphoma	Icatibant FDA Approves Shire's Firazyr (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
Tapentadol Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain	Crizotinib FDA Approves Xalkori (crizotinib) with Companion Diagnostic for a Type of Late-Stage Lung Cancer
Brentuximab Vedotin Seattle Genetics Announces Updates to Adcetris (brentuximab vedotin) Prescribing Information

September

Denosumab
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy

October

Tadalafil FDA Approves Cialis (tadalafil) to Treat Benign Prostatic Hyperplasia	Simvastatin And Sitagliptin FDA Approves Combination Therapy Juvisync (simvastatin and sitagliptin)
Albuterol And Ipratropium FDA Approves Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease	Deferiprone FDA Approves Ferriprox (deferiprone) to Treat Patients with Excess Iron in the Body
Exenatide Byetta (exenatide) Approved for Use with Insulin Glargine in the U.S.	Clobazam FDA Approves Onfi (clobazam) for Seizures Associated with Lennox-Gastaut Syndrome
Bupivacaine Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of Exparel (bupivacaine) For Postsurgical Pain Management	Eculizumab Soliris (eculizumab) Approved by FDA for All Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

November

Rivaroxaban FDA Approves Xarelto (rivaroxaban) to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm	Cetuximab FDA Approves Erbitux (cetuximab) to Treat Late-stage Head and Neck Cancer
Bupropion IntelGenx Announces FDA Approval of its High Dose Anti-Depressant Forfivo XL (bupropion hydrochloride)	Ruxolitinib FDA Approves Jakafi (ruxolitinib) to Treat Myelofibrosis
Asparaginase FDA Approves Erwinaze (asparaginase Erwinia chrysanthemi) to Treat Acute Lymphoblastic Leukemia	Aflibercept FDA Approves Eylea (aflibercept) for Wet Age-Related Macular Degeneration
Zolpidem FDA Approves Intermezzo (zolpidem tartrate) for Middle-of-the-Night Waking Followed by Difficulty Returning to Sleep	Infliximab FDA Approves Remicade (infliximab) to Treat Ulcerative Colitis in Children Older than 6 Years

December

Pneumococcal Vaccine Polyvalent FDA Expands Use of Prevnar 13 Vaccine for People Ages 50 and Older	Oxybutynin Hydrochloride Anturol (oxybutynin) Approved by FDA for the Treatment of Overactive Bladder
Oxymorphone Endo Announces FDA Approval of a New Formulation of Opana (oxymorphone) ER Designed to be Crush-Resistant	Azilsartan Medoxomil And Chlorthalidone FDA Approves Edarbyclor (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
Raltegravir FDA Expands Use of HIV Drug Isentress (raltegravir) to Children and Adolescents

Browse the FDA Approved Drugs by year

2013 2012 2011 2010 2009 2008

January	February	March	April
May	June	July	August
September	October	November	December

Drug Manufacturers

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Manufacturers

Pharma Links

Recently added Drugs

Become a member

Health Encyclopedia A-Z

Health Topics A-Z

Health News A-Z

Health Calculators A-Z

Drugs A-Z

Multimedia A-Z

Baby Names A-Z

Search Doctors by City/State A-Z

FDA Approved Drugs in 2011

Comprehensive list of FDA approved drugs by year. Drug information includes the drug name and indication of use.

Browse the FDA Approved Drugs by year

Browse the FDA Approved Drugs by year

Consumers

Medical Professionals

Medical Students

Directories